Interaction Guide · Research summary

Can I take Panax Ginseng with Heparin?

Review Panax Ginseng with Heparin: possible adverse effects and timing and monitoring, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

A bleeding interaction between Panax ginseng and heparin is unconfirmed. Human studies of tested ginseng products found little or no effect on platelet and clotting measurements, including when combined with aspirin.

What this answer covers

Oral Panax ginseng products with injected unfractionated heparin; American ginseng, red/white preparations and mixed formulas are not interchangeable.

Supplement or preparation
Panax ginseng
Medication ingredient
heparin

The human findings are mostly null

A randomized study of Panax ginseng alone and with aspirin found no clinically important overall hemostatic effect or significant bleeding. One participant showed inhibition on one platelet stimulus. A separate small commercial-product study found no platelet-function effect.

Heparin was not the study treatment

Neither trial measured bleeding during unfractionated heparin treatment. Aspirin and heparin act differently, and a small healthy-volunteer study cannot exclude uncommon complications in a sick or surgical patient.

Do not transfer results across ginseng products

The species, processing and extract composition should be checked. Studies and reports involving another Panax species or a blend do not establish a one-way effect for this exact product. The original abstracts also leave some formulation details unresolved.

Review rather than assume a dosing rule

Tell the heparin team about the exact supplement before starting or changing it. Report unusual bleeding or bruising promptly; serious bleeding, black stools or vomiting blood needs urgent assessment. Do not change prescribed heparin yourself. No universal avoidance recommendation or protective interval follows from the reviewed exact-product evidence.

Evidence and practical considerations

Side effects & toxicity

No qualifying exact heparin bleeding evidence; largely null human product studies do not confirm the warning.

Exact scope
Oral Panax ginseng products with injected unfractionated heparin; American ginseng, red/white preparations and mixed formulas are not interchangeable. with Unfractionated heparin sodium intravenous/subcutaneous, active-ingredient bridge to RxCUI5224 IN. Not LMWH or topical therapy.
Medication form and route
intravenous or subcutaneous unfractionated heparin; oral supplement

What remains uncertain

  • No universal risk estimate, dose adjustment or spacing interval; source-specific limits apply.

Factors that may matter: Exact product; Dose/duration; Other antithrombotics; Bleeding risk; Kidney function.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People receiving parenteral unfractionated heparin.

Heparin can cause hemorrhage; medicines inhibiting platelets can add bleeding concerns. Aldosterone suppression can cause hyperkalemia, especially with predisposing conditions or potassium-sparing medicines. Heparin is not absorbed through the gastrointestinal tract.

How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.

No botanical interaction specifically named. Not low-molecular-weight heparin, topical heparin cream or an oral anticoagulant; doses and risks of catheter flush products are not automatically equivalent.

Source 2: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Healthy volunteers; 24 evaluable for Angelica and 23 for Panax ginseng.

No clinically relevant overall effect on platelet/coagulation function, no added aspirin platelet inhibition, and no significant bleeding manifestations. A few participants had inhibition on one platelet stimulus.

How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.

25 volunteers recruited per herb; product standardization incompletely described in abstract. Aspirin is not heparin. Small short study cannot exclude rare bleeding.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Ten adult volunteers.

No PFA-100 platelet-function effect from any tested herb; aspirin control inhibited function.

How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.

Only ten volunteers and a laboratory platelet test. Not clinical bleeding surveillance in heparin recipients; original experimental component used, not the accompanying review.

Research assessment: · Open full citations ↗

Timing & monitoring

No supported universal avoidance or dose-spacing rule; product and clinical bleeding risk require individual review.

Exact scope
Oral Panax ginseng products with injected unfractionated heparin; American ginseng, red/white preparations and mixed formulas are not interchangeable. with Unfractionated heparin sodium intravenous/subcutaneous, active-ingredient bridge to RxCUI5224 IN. Not LMWH or topical therapy.
Medication form and route
intravenous or subcutaneous unfractionated heparin; oral supplement

What remains uncertain

  • No universal risk estimate, dose adjustment or spacing interval; source-specific limits apply.

Factors that may matter: Exact product; Dose/duration; Other antithrombotics; Bleeding risk; Kidney function.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People receiving parenteral unfractionated heparin.

Heparin can cause hemorrhage; medicines inhibiting platelets can add bleeding concerns. Aldosterone suppression can cause hyperkalemia, especially with predisposing conditions or potassium-sparing medicines. Heparin is not absorbed through the gastrointestinal tract.

How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.

No botanical interaction specifically named. Not low-molecular-weight heparin, topical heparin cream or an oral anticoagulant; doses and risks of catheter flush products are not automatically equivalent.

Source 2: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Healthy volunteers; 24 evaluable for Angelica and 23 for Panax ginseng.

No clinically relevant overall effect on platelet/coagulation function, no added aspirin platelet inhibition, and no significant bleeding manifestations. A few participants had inhibition on one platelet stimulus.

How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.

25 volunteers recruited per herb; product standardization incompletely described in abstract. Aspirin is not heparin. Small short study cannot exclude rare bleeding.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Ten adult volunteers.

No PFA-100 platelet-function effect from any tested herb; aspirin control inhibited function.

How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.

Only ten volunteers and a laboratory platelet test. Not clinical bleeding surveillance in heparin recipients; original experimental component used, not the accompanying review.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact-pair article preserving route, formulation, clinical-outcome and laboratory-endpoint distinctions.
Research summary published

Article revision: 04888b2fffcf03f2

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.